FBIO — Fortress Biotech Balance Sheet
0.000.00%
- $48.44m
- $25.38m
- $57.68m
Annual balance sheet for Fortress Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 233 | 306 | 178 | 80.9 | 57.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 24.7 | 23.8 | 28.3 | 15.4 | 10.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 266 | 346 | 230 | 117 | 90.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 32.4 | 34.1 | 33 | 23.5 | 17.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 333 | 397 | 294 | 168 | 144 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 51.8 | 101 | 128 | 84.9 | 71.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 233 | 288 | 253 | 145 | 121 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 100 | 109 | 41.7 | 22.5 | 22.7 |
Total Liabilities & Shareholders' Equity | 333 | 397 | 294 | 168 | 144 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |